Welsis (WLSS) FCF Margin (2022 - 2023)
Welsis (WLSS) posted quarterly FCF Margin of 423.3% for Q4 2023, down 24581.0% year-over-year from N/an in Q4 2022, and down 2297.22% quarter-over-quarter from 19.27% in Q3 2023.
Welsis (WLSS) FCF Margin (2022 - 2023) Analysis & Trends
Welsis' FCF Margin history runs 2 years deep, the most recent figure standing at 423.3% for Q4 2023.
- In Q4 2023, FCF Margin fell 24581.0% year-over-year to 423.3%; the TTM figure through Sep 2024 stood at 1498.95% (down 142817.0% YoY), while the FY2024 annual figure was 1498.95%, down 142817.0% from the prior year.
- FCF Margin for Q4 2023 stood at 423.3%, down from 19.27% in the prior quarter.
- The five-year high for FCF Margin was 25.77% in Q2 2023, with the low at 423.3% in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 127.46% |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 0.38% |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 23.01% |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 10.19% |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 46.84% |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | -27.00% |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 13.54% |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 25.33% |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Welsis | 1.65 Mn | 1.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -423.30% |
| Sep 30, 2023 | 19.27% |
| Jun 30, 2023 | 25.77% |
| Dec 31, 2022 | -177.49% |